6 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
, social and governance (ESG) initiatives that may benefit the patients we aspire to serve, in a manner that aligns with our organizational culture, core … values, and applicable regulatory requirements. Our board of directors provides oversight over these ESG initiatives by reference to those standards
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
, or ESG, activities. Tyme risks negative stockholder reaction, including from proxy advisory services, as well as damage to Tyme’s brand and reputation … communities, corporate governance and transparency and employing ESG strategies in Tyme’s operations. A growing number of states are requiring organizations
S-4
SYRS
Syros Pharmaceuticals Inc.
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
’ environmental, social and governance, or ESG, activities. Tyme risks negative stockholder reaction, including from proxy advisory services, as well … stewardship, support for local communities, corporate governance and transparency and employing ESG strategies in Tyme’s operations. A growing number
- Prev
- 1
- Next